Ignyta to Present at Jefferies 2017 Global Healthcare Conference
June 01 2017 - 7:00AM
Business Wire
Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company
focused on precision medicine in oncology, announced today that
Jonathan Lim, M.D., its Chairman and Chief Executive Officer, will
make a presentation at the Jefferies 2017 Global Healthcare
Conference on Wednesday, June 7, 2017, at 10:00 a.m. Eastern time
(7:00 a.m. Pacific time) in New York, NY.
A webcast of the presentation will be available during the
presentation in the Investors section of the company's website at
https://www.ignyta.com/investors/, and will be archived and
available at that site for 14 days.
About Ignyta, Inc.
Blazing a New Future for Patients with
CancerTM
At Ignyta, we work tirelessly on behalf of patients with
cancer to offer potentially life-saving, precisely targeted
therapeutics (Rx) guided by companion diagnostic (Dx) tests. Our
integrated Rx/Dx strategy allows us to enter uncharted territory,
illuminating the molecular drivers of cancer and quickly advancing
treatments to address them. This approach embraces even those
patients with the rarest cancers, who have the highest unmet need
and who may otherwise not have access to effective treatment
options. With our pipeline of potentially first-in-class or
best-in-class precision medicines, we are pursuing the ultimate
goal of not just shrinking tumors, but eradicating cancer relapse
and recurrence in precisely defined patient populations.
For more information, please visit: www.ignyta.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170601005180/en/
Ignyta, Inc.Jacob Chacko, M.D.CFO858-255-5959jc@ignyta.com
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Apr 2023 to Apr 2024